Screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation

Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis

(2018) Stephanie Roberge et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Meta-analysis on the effect of aspirin use for prevention of preeclampsia on placental abruption and antepartum hemorrhage

(2018) Stephanie Roberge et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin on length of stay in the neonatal intensive care unit

(2018) David Wright et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

ASPRE trial: incidence of preterm pre-eclampsia in patients fulfilling ACOG and NICE criteria according to risk by FMF algorithm

(2018) L. C. Poon et al.   ULTRASOUND IN OBSTETRICS & GYNECOLOGY

Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE

(2018) M. Y. Tan et al.   ULTRASOUND IN OBSTETRICS & GYNECOLOGY

Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia

(2017) Daniel L. Rolnik et al.   NEW ENGLAND JOURNAL OF MEDICINE

Impaired placentation in women with chronic hypertension who develop pre-eclampsia

(2017) A.  M. Panaitescu et al.   ULTRASOUND IN OBSTETRICS & GYNECOLOGY

Chronic hypertension and adverse pregnancy outcome: a cohort study

(2017) A. M. Panaitescu et al.   ULTRASOUND IN OBSTETRICS & GYNECOLOGY

Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation

(2017) N. O'Gorman et al.   ULTRASOUND IN OBSTETRICS & GYNECOLOGY

Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation

(2016) Neil O’Gorman et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Contingent screening for preterm pre-eclampsia

(2016) D. Wright et al.   ULTRASOUND IN OBSTETRICS & GYNECOLOGY

Competing risks model in screening for preeclampsia by maternal characteristics and medical history

(2015) David Wright et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Committee Opinion No. 638

(2015)   OBSTETRICS AND GYNECOLOGY

Uterine artery pulsatility index in the three trimesters of pregnancy: effects of maternal characteristics and medical history

(2015) A. Tayyar et al.   ULTRASOUND IN OBSTETRICS & GYNECOLOGY

Serum pregnancy-associated plasma protein-A in the three trimesters of pregnancy: effects of maternal characteristics and medical history

(2015) D. Wright et al.   ULTRASOUND IN OBSTETRICS & GYNECOLOGY

Serum placental growth factor in the three trimesters of pregnancy: effects of maternal characteristics and medical history

(2015) A. Tsiakkas et al.   ULTRASOUND IN OBSTETRICS & GYNECOLOGY

Mean arterial pressure in the three trimesters of pregnancy: effects of maternal characteristics and medical history

(2015) A. Wright et al.   ULTRASOUND IN OBSTETRICS & GYNECOLOGY

Competing Risks Model in Early Screening for Preeclampsia by Biophysical and Biochemical Markers

(2012) Ranjit Akolekar et al.   FETAL DIAGNOSIS AND THERAPY

A Competing Risks Model in Early Screening for Preeclampsia

(2012) David Wright et al.   FETAL DIAGNOSIS AND THERAPY

Protocol for Measurement of Mean Arterial Pressure at 11-13 Weeks' Gestation

(2012) L.C.Y. Poon et al.   FETAL DIAGNOSIS AND THERAPY

pROC: an open-source package for R and S+ to analyze and compare ROC curves

(2011) Xavier Robin et al.   BMC BIOINFORMATICS

Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks

(2011) Ranjit Akolekar et al.   PRENATAL DIAGNOSIS